December 13, 2024 02:13 PM Eastern Time
BrightPath Bio和Cellistic宣布就iPSC來源的BCMA CAR-iNKT細胞第一期臨床試驗展開製程開發和生產合作
View Full Size
Download
Full Size
JPEG, 1476x542, 211.5 KB
Small
JPEG, 480x176, 39.3 KB
Preview
JPEG, 144x53, 6.5 KB
Thumbnail
JPEG, 120x44, 4.7 KB
Smart Multimedia Gallery
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
æ°æµªå¾®å
騰è¨å¾®å
QQ空é
QQ好å
Email
All News
|
News with Multimedia
>
Press Release: BrightPath Bio和Cellistic宣布就iPSC來源的BCMA CAR-iNKT...
Get Business Wire News on Your Website
Terms of Use
|
© 2024 Business Wire